                           ˿µϣ20090819գ

09.08.19, ӡȫ񲹵òã
09.08.19, anglor人кԺִаӷ
09.08.19, YushФţƪ
09.08.19, ϻţһ㲻ţйҪŵҽѧĲֹФһˡ
09.08.19, йɫĻҩĿ¼
09.08.19, ppcgϣһⱾġǻۡ
09.08.19, ڵıҽƭӺԣƭʵһ
09.08.19, ʤȡҽ֪𱯾硷
09.08.19, 㡶ձٵ촦
09.08.19, һλںıˡѧڵĹ¡
09.08.19, СҽԺƽڴ̱˳ԾһͶ
09.08.19, СϺѧ÷սԾ֤֮
09.08.19, ˮɳ滮Ҵɳˮҥԡ
09.08.19, ǡѧѧԺĹͣʮģڵ͸ԵϢ
09.08.19, ÷ӡҵĺС񫡱
09.08.19, ָ䷽⡱ º
09.08.19, ֵ廪԰ռ

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

                                ȫ񲹵òã

                                   ӡ

    1994йʼȫʳüӵΣȻȼƻߵʵʩ
׵öࡣ2008ĳ飬ȫθѴﵽ97.48%һʱ䣬ý
ͻȻһ浹رɡһߵĺһλʱվε
߶ȣеΪһԽܵ뼯ȨΪ˵ǵ
Ȼŷһ͵ġȫȨᡯҲԼӵεȨơ

    ʵⲢһйɫߣйϹĿٷӦ
1993꣬ͨ飬Ҫȫʳμӵķȱ
֮ǰѾôˡôǡǡôҲ㲻ϡȫȨᡱ
ʿϸ20ʵȫʳμӵ⣬˵ȱ
û˱ԹȻεȨûа

    ֵεķ㽭ѧҽѧԺһݽڣýߵ
Ǹ˵ĶýڸһˣйӪѧһݱʾ
оվΪ11ˣũﵽ17ˣζţĿǰ
϶ÿκ2050΢˼㣬йÿﵽ˾˵220850
΢ˣԶԶ֯200΢/İȫߡ

    ҽѧԺڵͷΣȥΪȨȴûԡ֯
Ĺƣδӳ۹У⺬ɥʧ20⿹Уֻɥʧ
20ζйÿӵĵʵֻ140540΢ˣô
ˡң֯ûл200΢/İȫߡ֯Ľ
ÿӦ150΢˵⣬иͲڸŮӦӵ200΢ˣεĺ
ǸƼǺƶġ

    Ƽǰȫߣﲻܻʹȱ⣬ȴδ
ؾͲȫ磬ݵ飬ôһЩŷ޹ҵĵԼÿ500
΢ˣԶýڻİȫߣҲûǵҽѧԺھǸ˵Ķ
ô֯İȫǶأÿÿǧ30΢˵⡣һ60ǧ
ص˵ÿ1800΢ˡĵͨҺų
ÿĵһȫߣûгֲӦձʳд
ʳúǳߵĺ壬ÿͨߴ20003000΢ˡ

    ˰ѳԵ˵÷ǳ£˵ǻӼ״ٰķʣû֤ݵġ
˰ѽĳЩ״ټӹеΣ⵹Ǻܿܡ
Ҳڵȱеʱ״ٻܿķʻӡ
ʵһ֡ȻӦǼ״ٵĳɷ֣ȱĻУΪ
ϳ㹻ļ״أò״ٵôһˣ״
һʱڲ״صķ࣬ͻּ׿ʱ
󣬹һʱ״ٵĴСͼ״صķ

    ˶ԵرУġƼĵշ״ټ
ǿɿơƵġ෴ģȱĺҪصöࡣһȱ
һ˶֪áӲ״״󣩣ʵּϾơ
תǺܿ¡ȱصĺǶӰ졣иȱ⣬̥
ӤĴԻֲת𺦣²תϰͯȱ
⣬ѧϰҲܵӰ죬̵¡ʹжȱ£
ͯҲή1015ȱǵϰҪĿԤء
֯1994ƣȫн16˿ȱ⻷У2ǧ
ⷽ棬йء2007꣬֯йÿ껹121.9
ûеõⱣ

    еʱƹӦðѲȨϰԼѡ
ȥֻܺǾջһƽʱĻԼ˵
ǷӦصز⡣ȱӤͯ˺һɣھ
ˡȫʳμӵԤȱЧҼˣ֯Ĺƣ
ÿÿӵķֻ5֣ԺԲơ֯
ȱģɺ컨С֢ͬΰĳɾ͡Ըһΰ
̲ΪһЩйʱҵĿˮ֮

    еβھҪž޵ΡЩ˵״˳ԵΣʱΪ
˺ԼȨԵΣҲӦɡڸߵǿƵεıҪ
ЩطҪĵǺƷĺΪ
1633180΢/ǧˣƽ832΢/ǧˣϺĺΪ308-1300΢/ǧˣ
ƽ798΢/ǧˣԶȵθˡ

2009.8.17.

й걨2009.8.19

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

人кԺִаӷ

ߣanglor

ûмԺʹִвöȫģݲԺԺ
ΪִһǺԺڱִйеΥ
桢ΥΪԶ׼ġ

һִΥ档Ժйй淶
ԺִкͽڻЭִе֪ͨ1涨Ժۻִڽ
ڻģִԱӦʾ˹ִ֤й֤߷Ժۻ
Эۻ֪ͨ飬ӦЧ鸱Ժ
ԺִйĹ涨Уڣ涨ִԱִй
ʱӦйԱʾִ֤й֤涨װ涨ִ
й֤ԺͳһƷȫԺѾ°ִй֤
ϵͳΪʡõľ֤ͳһΪλ֣ʡķԺ
Աִй֤Ϊ610*****°ִй֤200871ЧЧ
Ϊ5꣬ԭִй֤ͬʱϡһλںʡԺĴѧͬѧѯ
ԺβûкԺԱдִй֤ıǼǣҲ
˵ԺԱдδͨʡԺ˻ִй֤ʸ
дΪWH01037֤Ȼǹִ֤й֤

йԱһִֻԱĹ֤ӡִй֤
棬ҲҲ֤αļΪĳЩԺ˽ִй֤Υ
참󿪷֮ţִ˺ȴԴȫȻ֪

ִгΥҹϷ216һ涨ִԱӵ
ִƽִ飬Ӧִ˷ִָ֪ͨ
УڲеģǿִСִгزٵĲ裬
ԺȴԴ涨ӶѡԵ߷218219220223һ
ͷǴִδǻҲ
ԺΪִǷϷԺȼδͽ
þ֪ͨºҲδִ֪ͨˣڹ֮˼ӵӰ
죬ԺһȻΥִΪڶ޹սĿŵ٣
ǶԴ˱ʾķ߿Ǵ

Э۴֪ͨΥ沢ӷһֱơͨ
֪ǩΪ200987գӵĴһ챻ߵģĪФԺ
ܵǩ˻۴֪ͨ飿ԺĹ涨Э
֪ͨӦԺں˷ö֮ͬʱǩִԱǰȥ
ִСҪִзȷִ˼Ʋ׼ȷԣͬʱԺ
ԡԺ87ФǩЭ۴֪ͨ飬ȴ
ܹڵմ人ϵ۱ִ˵дִֻԱ
֪ˡ

Фۡ졢дλٴˣڵأ˼
ҴǼΪϷִʵӷ°ɡǣ
дλЯкԺԺӡĿհЭ۴֪ͨ鵽
б֧»索л۷˵ĴӦǺ
йԱ˶Բȷϱ˻ֺ˻Ȼ
еһֳдЭ۴֪ͨ鲢ǩһǩФ۵Ĵ
ʹСйԱԴϰΪֻҪṩɹ涨ķ
֤ɡ

ΥЭ۴֪ͨ鲢˵ԺٵķΪФ
ɣ渶ִз1260Ԫв֧참Ա̳Ʊ
ãҪ˵ڱʳ뽻ͨȸַáڵǰ참˽ŵ
ԺԺáΪФǣФ˻˻
ʽд87գǡ壩֮ǰ͵Žͨ
ʳ޵ȣ˳۷˻֮ĩ֮ڱңһѺظ
Ժдλٱ֮УżٻФ
һԪǿҽ人кίɼίԱ򺺽Ժ
ڱṩе顣

ΪƲ⣬Ժܹʾдλٴ˴α
֮еĸֺƱݲǵĺ˵ùȷǺ
참anglorԸ⹫Լʵݣеһɱ
ķɺʣԺдλ٣Ǹ

⣬ȫͬʦĹ۵㣺ϵ˸
ծ񣬾Ƿ޹ͬծһ˵ڷ޹ͬծ񣬶ִвö
õķ֮һǡл񹲺͹ʮĹ涨ڻ
ϵڼõвƲ޹ͬСܷºҲ
ӵġʿʺšΪԺķû뱻ִ
˽κιͨ£ȫųǱִ˻ǰƲĿԣ
ΥۻǷԵЩ³ç벻Σ

ǿҺйزŽԺԷäФ۸ԺΪ׵ġӷΪ
ֽ졢дȷٰٶ飡

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

Фţƪ

ߣYush

һФֵġйٴԼйΨһʵʩνФ
Ϸ仡ġ֣ԴҽԺѽü
ٴƹ ѳɹơ90ͨBeaumontҽԺоЭ
Աstudy coordinatorCindy Turzewski֮ƭѯʵĻ߼ҳ˵
йΪֶΣФҽѾ̸йдҽԺ
ҽйҽԺ춼鲡ֱȥйФ


ФΪBeaumontҽԺйĺãѳ
ԴʹʧҩDitropan¡µķ仡԰
á谭˴ԵĹ顱ФҲЧͶߵ
˿ԲûжʱſΪԲ˵ͣҩʱſЩ
ҪҽȻδ£пʵϣKevin Bryantǰ
foxnewsϡЧĸѯʺδܵλ
ỼߣĸKevin췢ӣЩͱҪ3
6ͣDitropan

Фţ񫡢ƪһܶ׫ֻţ
λ(EmailsͬʱתDr. Xiaowill won the 
Nobel Prize

μ

1. ֣ԴҽԺýš
ýCNNɷáФϷ仡
Դйٴ ʱ䣺2009-6-12 14:57:28
ФҲѽüٴƹ㣬ѳɹ
˻ߡѼĤͼ´Сʧ90

2. λ߼ҳӣѯBeaumontҽԺյCindy 
TurzewskiФĻغ
http://spinabifidaconnection.com/showthread.php?t=370
08-19-2008, 03:17 AM
sanguine

I inquired about the Xiao technique with the folks at Beaumont 
hospital. It seems they are still accepting potential candidates (my 
daughter is too young - the candidate needs to be at least 6 years old) 
Anyway, here is the response I got:

In China, this procedure is now standard of care. Dr. Xiao has 
taught this procedure to surgeons at all the major hospitals in 
China

Cindy Turzewski, R.N.,
Cynthia.turzewski@beaumont.edu
248-551-3355

12-17-2008, 01:36 PM
kali

I have found parts of the doctors emails,

In short, your sons neurogenic bladder and bowel due to spina 
bifida can be cured by the procedure. I can schedule your son for the 
surgery at the end of the year as the earlist in Shangahi, China. 
There are too many patients waiting in line. We operated on 620 kids 
with spina bifida in 2007 and number is goning to double this year.

Please keep in touch.

Chuan-Guo Xiao, MD

>> This surgery is now standard of care in China. Dr. Xiao has 
taught this procedure to surgeons all over China. It is done everyday 
in hospitals in China. If you really want to have this procedure done 
on your son, we would suggest going to China. If you are at all 
interested in going to China, I would be happy to forward your 
information to Dr. Xiao. I have done this with other families. ˶
ΪCindy TurzewskiҪתФ鲡ֱȥйФ
ʼƶͥҲôġ

3. Фס˹
ФϷ仡ԼФXiao Procedureչ
ͽ: ˹  2009-08-15 04:08:56
ǣҷ֣ûйôãиƣ
һHOME RUNȫһƫƫǸûκЧ
ǸŮʱ꣬6·仡ͳˣ
ǳģΪ綼ȫˡô£ϸ֮£֪ԭί
Цá

ಡһֱǲ֢֮洦һֱҩDETROPENࣩ֮
׼ȫԵΪÿСʱһΣCIC
Peters˹仡񾭳úȻֳ棬µķ仡԰
ãҪ谭˴ԵĹ飡 Petersͣκ
ҩֹͣò˴DiaperԼ⣡--ֱҪԼ
µ񾭿Э

4. Kevin Bryantĸ׵
http://sci.rutgers.edu/forum/showpost.php?p=586207&postcount=34
12-28-2006, 04:08 PM #34
BeeBee
He was not taking any Ditropan, etc., before the surgery. But the 
other 2 patients were. They were asked to cut it by 1/3 a week prior 
to surgery, they will cut again in 3 months and completely stop at 6.

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

йҪŵҽѧĲֹФһ

ߣϻţһ㲻ţ

ҿФɹʸߴ87%ʱҸ֪ҹҽѧ
йӻԻ͵ĳɼ50ҹѧңͬѧң
΢ҵ硱ֲҽѧһհס60
شҽҽѧ硣

ϸ£ҵĲˣˣ֮ϵġҩ 
91.7 θ92.3ĸΰ95Ĵ󳦰90ٰţ죬
вˣйˣ֮λڹ޵ľҽѧԺĸţƵҸҩ
99.2ҸΣûκθã

ҿԿ϶Ԥ⣺ڲõĽй˵ŵҽѧĲֹ
Фһˣ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

йɫĻҩĿ¼

ߣ

ͷҹһҩƶȽ衷ˡҩĿ¼
2009棩

֯1977꿪ʼ䲼ҩ׼嵥ÿ£
20073£Ѿǵ15ˡ֯200710𻹿ʼ䲼ͯ
ҩ׼嵥

뿴
http://www.who.int/topics/essential_medicines/zh/index.html

֯ġҩ׼嵥°340ֻҩִҩ
Ҳҩҹ°䲼ġҩĿ¼307гĻҩ
ûогҩƬ307гĻҩУѧƷƷ
Ҳҩռ205֣гҩռ102֡ҩѹҩʵȻ
ҩƬءվҩĿ¼йҩƬô˵ġ䲼
ұ׼ҩƬΪһҩй涨ĳ⡱ûҩ
ôĪ⡣֮ҩƬӦǺܶࡣĿ¼а䲼ҩ
ʵǴĳҩˣҩĽҹüˡ

ϸгҩĿ¼ȻҩעҺעҺ 忪ע
Һ עҺ עҺ Ѫ˨ͨעҺ ѪͨעҺ עҺ)
ֲ̫ˡ

켫һʱȲעҺעҺѾΪˣ
زŽͳֵҩƷܵȾܵȾҲȫ
ͣãùҲΪԭˣҲûͣáҩע
Һֵ⣬йز֪ԭģԸͣˣûȾĲƷ
Ҳͣˡ

ÿοҩ˵飬ῴҩƷĹʣѧʽ
дָҲϸгҩ˵ҩƷĹҲˣ
Щֲѧʽǿ϶д˵ҩľɷݲ
ûд˸оûиãǺٵĸáһҩָ
ãһ䡰ҩֶ⡣

ڷɷݲҩһҲʲô⣬˵ĿǻŻһ
ƤӣЩɷݲĶ뿪Կڷҩͳʳ࣬
ʳĳɷҲܸӣûʲô⡣

ǾעͲͬˣҩעҺɷݼ򵥣ֻǳ
ҩעҺĳɷݻǲʺܸӣⶫѪע䣬
²Ź֣ҳԭҲ

γ̨Ŀ¼205ҩҲˣ縴Ϊ
θԭ߰θҩ˲٣оθͦЧ¹ԭ
ûˣɹԲĸθˣԭθεĻϼЩ
ݲҩ֯ġҩ׼嵥гθ
ҩ涡þټ˱ȽڵȨ
Ծ͵ҩȥҩ嵥þгǿڷҺоþ
ֱ֣涡ûУУ3Ԫ100Ƭдϲֻ
ҩСڹ̨ײ깣̨λöǼ۸ߵгҩó
һСƿһ -ٿƿд˵һֽеָ
ҩγ̨Ŀ¼ҩ֡

йʲôйɫѧҲҪйɫĿѧҩע
Һܲʽ뿪ʷ̨û뵽γ̨Ŀ¼ڼƼҩ
עҺǡԹҵϰƼҩ˻רңй
ɫĻҩĿ¼޸һأҲָҩռеļ٣
ҩעҺʧй˵Цˡ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ϣһⱾġǻۡ

ߣppcg

пⱾ飬о̫ˣⱾܻ𱬣
軹CCTVϣҶһⱾ顣

ǻۡһ൱飬ܶĹ۵㣬Ҫ
ҽѧ֪ʶֻƾʶͿжǶǴ

ⱾΧšѪ۵չģٵӣȴܶ
ܶʵ롰Ѫϵ˵ǡѪͲġ

ĶͲ̸ˡ

ѪΪʳеĺݣⱾѪ뼲
ķȴ򵥵˷Ц߿ּٹѪģ
ֻԹѪǷ㹻ģܶ༲Ҷ֪ǹѪ
Ƿ⣬漰ܶิӵءʹǹѪ㣬ԭһҲ
벻ģ˸̸ͨʳ

ʳƵ˵ӻܶʳֻоθֽС
ʲŻᱻգЩСʿԷֳɰᡢ׵ǡ֬ȣ
ʳﾭֻиӪɷֵĺͬûⱾ
˵ô

ŵΪѵġѪֱӽעҺ硢
Ѩλֱע䣡ں滹ϸԼע䵱עҺЧ
ĸ׺עЧҩעҺϽ֮ͣ
£߾ȻΪֱӳ硢ѨλֱעͼӰķ
ֱǽɱ

췽ҹ̷׸ӲҲַͨ
+ʳƽǺǣйǧҸλǶоˣ

⻹ʲôиƷײʲôʪؽʹ
ʲô״ײʲô뿴θθʳҲ
ơե֭ò˺ȣθθʳθθ
ĻӦոʱȣֻȼھͿˡʳĲҪڴϣؽ
֭£ʼھˣʳ֭ÿ23Σ12
ھͿԵظֲ񡢰Ĳλססֹʹ

ôΰķΪβҽѧרоۣΪλ䷢ŵ
߻谡

ⱾһЩйҽɼ߶ִҽѧ
˽ⲻ࣬ҽԼģΣ

첻㣬2ʱֻףΪƲʱȾ
ԼСףѪ򡣵ʱҽ׼üƣĸ׼ԡ
ĴѰƫҵһֽСţϥĲҩĸˮҺȣ
ͿסѪ򡣡

ʵСײҪüƣҪüƵۺ

޷һһо١ѧ֮ҽѧ֪ʶ
ţִҽѧۡ䲻Σգȴ
ɵŷа˵вĻʱ

ٴϣиһⱾ飬ƭ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ҽƭӺԣƭʵһ

ߣڵı

085215㣬61ͯڻ11죬뺢13727
67죬˻ῪĻ80,ССʱֹͣˣԶͣ
һ̡ǰְһһĶССǻؼ
ˣҲҩˣҲˣҲÿˡССҪסְ
ӣٵߡʱ
Ӷֱ÷ȥڰְ軳еı䡢䡣

077ⳡجοʼӣССղμСѧҵԣԼϲ
ѧͰ༶߸˵ĵѧȥУ
û뵽ҲûлѧУţУҲûлᴩˡؼҺ
ְ跢СС·жԭٻͺزסˮҪ7
17ȥҽԺ飬ͨCT,ŹƬҽССҴˮ
ԲְϢˣţ
ȥϺɽҽԺƣһССԼķ߳Լ
ޣ˵οҪǺܶǮɣƽʱ3
ԪǮȫˡŶµĺӣְСС̤Ѱҽ֮·

ϺסһϣڶȥɽҽԺҽƬӡ˺ӵ
Ϊ˫ེѹԻˮΪλ̫Χ
񾭸ûа취ֻԻˮССֻסԺ
ȴСС˵û뵽ϺһجΡ˵ج
ˣССͺˡССȴش𣺡جεĿʼ
ᣬȴԶԡ727ССգǰһСС
ңСС϶ܺȴûڰְǰ¶һ
Сʱڴ𶯣ҪССƳˣֻ
СС۾ֲֻͣĻӶҪȥץʲôͽ֢
ңͼ˸ְȥ̳ССϲϷ
ϣССһ۾ܿԼҽ˵ССָĺܺã
Ϳ´ˡСС˵ССˣȫȥΡ
ССȴش𣺡ҲȥϣҪȥˡ辪СС˵
СС˵˵áպôպôþ͸
ˡһCT鷢һߵһˮȥˣһߵĻˮ
һûб仯ҽ˵ǺҲͨҲԭ򣬻Ҫ
һССһαƽңСС̫˵ˣʹ˵
Ҳһ£һߵˮһֻֻҪڳϷ
ҽ˵ԻˮˣĿǰûһ취ǿ
жͻȫֲ̱ˡһڣְֻôССؼ
ˡ

صҺ󣬰ְ赽ϣҵõרҽܹȾСС
ΪչССÿؼҸССιһСС˵ÿؼ̫
ˣҪˡôܹأǺ´ѩǼ죬·
ûߣҲÿȥССιſѧһٽ
ССĺǵССûУҲûְҪ
ǲǵġһССһոµɰСС
ˣͣȥ˵ҪǦʺСˮʡ
Ӹľ߷ȥѧ˺áССһ첻
ˣԽԽѣԽԽ˵ֻܽ裬ƽһ
ҲѡְִйõǱ̳ҽԺϵñĳ
壬ϣĴССɻȥҽҪССְĴ
ó

˷ɻĳǽӵ̳ҽԺԱߵһùݣҽԺ
˽ǡڶְȥҽԺ˽֪רһ𿴵
һҹСרʱҪ
Сְ֡衢ССϣ廹ССԼ08굽˻ᣬ
ССòСдԼĲ顰1۾¿2ˮ3
˵д¡Ҫȥ찲Ź㳡ְССһȥ
찲š˼죬ڵȵ˴ʱ䣬ϣʮֲ߽ҽԺ
ҽϸƬӣССȴССȥ԰ְ˵
ԣûа취һ·ƣЧҲ̫ã
ӿҪסְǿ᲻ҰʵСС˵ֻ˵̳ҽ
ԺͻɽҽԺҽ࣬ССؼȥõġϣ
һˣСС·ԽԽˣְССؼˣС
СҪְֱŲ¥ˡ

صССԽԽһ֣Ų·ˣ
ȭͷսſҲѣͷҲˡһΰְְƻãг
СССץһôҲҧֻƻ
¼ϸϸӡֻɰְִóԺ󣬳ˮҪե֭
ԣҪִܶϷ治˶ͷ͵ȥ
Ļˡʮ·ݸµˣССʼ켸ҹ˯
ţÿӾҪ鶯΢е۾Ҫ鶯ְСС
ҽԺȥƣҽϰѺӽӽICUICUͲü̽ˣ
ֻȴǵ˵ڶ磬ҽ˵CTƬӿС
СһԻˮܶһҳˮѾڰ״̬
ҽԺûûа취ƣҪתԺְ輱ûа취
ĴһЩҽԺһСһڻؾûа취
ְȥһҽԺҽ˵ֻ˵Իˮ
ҽʿ˵ܽܣֻзҽǿ˲°ǿ
סԺ֤ǸϽѺӽǡܻظҽԺ120
ȻѺӽӵһҽԺҽʿӶ˵⺢ôˣ
ҽϰССڶǿСС
̨ȻССˣȫҶлҽ
һʼƭеǸĵڶ죬ССˣ۾
ССǿһһθܣԷֻעҺ壬
ССѾûһˣȥûлˡϣһ
ְ࣬վССιСС࣬ССԼŲְְæ
ССǿһһڰȥССÿһڶôѣ費ͣ
ιţССͣţְˮͣţССһࡣ
ļССһһڵĳԣһһڵιССͦˡ
ҽ˵԰εθܺˡǣĥСС֡ҽҲ
ˣΪȫֽŲûб飬˵ҽΪСС
ʧȥ֪ˡǰְ費ţҹҹССߣͣĺ˵
Ħ˶һְֶСС˵ССſһֱսСȭͷԼ
ɿˣְ˼ΣССˡСС˵أ
һҪССҽáССĴ۾ͻȻˣ
ǰѺӲʵҽҽƬӿ˺ӵ
ǣԻˮˣҲް취ҽԺס
һ£ֻôӻؼˡ

ؼҺССѾȫܶˣֻڴϣְһһ
ҹҹССιССˮȹ֭࣬޽С㣬¿㡣
СС˯ˣְҸҽϢ0712²鵽
ϺҽġԣƳˡ㶾ơģʽ
ԲЧְԺ󣬵ڶɰְȥϺ˺
ԣڣѺӵĲҽԺϽCT
ŹƬӴȥҽһ䡰šһ4ÿ5Ƭҩ
ְֲҽûпõĲԣ˵ǰһݵĺ
ҲֲѾȥѧˡְ˺ܸ˸С
СϣˡÿȥһοԣڵȻ
šһѩְ֣ڸٹ·³12СʱȻ
Ϻ䣬ΪﴧŵġšҪȥССû
µġšȥˣʣƿССȴҲҪˣ
ԭνġšȫƭ˵İϷ

085185㣬ͻȻСС촽ʧȥѪɫͫ
Ŵ󣬰ְָϽССڶԿ˹ͬʱز绰120Ȼ
5복ϰСС͵۴ҽԺңҽϸСС
ȣССѪѹȶǵѪѹֵȥ
ѹ30200£ҩȶһ֮ҹ
ȥȪˮбֽıⶼǺɫ19~21ȫգСС
ͦȥôڴ߲ͣĶСС˵ССһҪͦȥŶǾ
Բģ벻ССССҲ벻衣һ죬
һҹһ죬һҹ5215㣬СС150~ 120 
~ 100 ~ 80 ~ 70 ~ 60 ~50ˣССӶųˣԶ뿪ˡ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ҽ֪𱯾

ߣʤ

2009818աձһΪҽط  ٵ
ֲϢֲ7ƽ£Ϊһλ
70ꡰҽġҩط濹ųҩ˥ߣʹ
ɹ7ֲʧȥܣҪ͸ٴֲ
е߰ķá

ž458ҽԺֲ˵û뵽֮׵ֲȴ
ҽҩˡֲϣζŰƵıԵ
֪ҽսִҽѧѧɵһ𱯾硣

λ70ҽ֪ţɵ󵨣Ҫáҩط
濹ųҩʵ֡ҩšѹͲֲ֪ų
ҩĿѧԭϵѹûٴҽۡ
˵ġͲִҽѧͽѧѧ
ֲҪˮϡ֪Ȼؼ
Ĺǡ

Ͳֲ֪ΪҽƵġطǴ
ģֻһֺϺ߼ĽͣΪ׬ǮΪ˺ƻ߼б
ġҽǵıΪǱɵģ˵ġ

Ҳһ70ҽʱһλڵغҽѧϰҽ
ʱҺִ֪ҽѧ֪ʶеܵġ磬һ
ոкĲˣĽǲ֣ҩòǷֿͻ
Ѫʹ㻯鵥֪еٴ壬ʵһߡ
ҵʹ˿ҩҽƺа뵱Ȼ
ʵ˼άƣ뵱Ȼǻɴġ

˱䱾˺ͼҲεģˡ70꣬
šطšҩȻҲоϵĿǣΪҩҩˡ
ǡǡ෴˴ǮֲˣҪǮ͸
ѱ

Ӧṫڶԡҩҩط֮˵ľ
Ӧѧۡ

ӳܶ⣬繫ҽΪĽ
֪ɵҽԼ͹ҽǷĳشʧ󣿡


ձ2009-08-18  21  ҽط  ٵֲ  
Ѷ ͨѶԱᣩ·һֲ7
ƽ£ȴΪŽֱҽòҩ濹ųҩֲ
ϣ˥߶
磬ڽž458ҽԺ͸ҼڲϽ͸
ơҽԺֲθ߼ߣǰûǮֲҾ
һҵʱ˺ܴľĸȰϡû뵽֮
ֲȴҽҩˡ˽⣬7ǰֲ
ָãȴҪڷҩԿų⡣ųҩÿҪ
Ԫڵߣǰмҩĸ˵
ŵĻʶһڽֱ߿С70ꡰҽλ
ҽƿͨҩһҩط
Ϊ棬ҩ˶ˣǰȡҩ40죬ҽ
Ȱ˵ˮϡ
һ£𽥸е֫ᱳʹԼϰࡣһ
ǰڼͻȻε͵ҽԺȣѾص˥
ߡȻסˣѵѡ͸ٴ
ֲ߶ø߰
ޱʾĿǰҩֲֻĲ֢ܴҩ
ų⡣߱ҪְʱҩڵҽԺ飬һвף
һҪҽԺܿѧơ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ձٵ촦

ߣ
http://www.sciencenet.cn/m/user_content.aspx?id=250177

ձѧѧѧ־ϸ(Genes to Cells)2009
ºȫķ˸ûرԴѧɼҰ(Akio Sugino)
һµı漰ýڵĻӦидһʱûҵڵ
ýһڵһ䶯¼뱨򵥻ع¼ľ

20068£ɼҰʵҵĹԱУͶ߽JBCƪ
б֮ӣպѧɵ飬922չʽ棬֤ʵɼҰ
ȷ٣漴ΪϷԵǣ91һλٱߡɼҰ
ʵڵ42ڴ鱣(Yasuo Kawasaki)ʵҷɱȻ
ձɱʽϸ߶Ҳ˾ɱٱ޹أȷΪ
˼𺳺͹ء

һ¼ֵసǰᵽĿ˹ҷӡ
ѧһͬǣѧԱڴ˰ȫˣֻϰ塣
ǡǡ෴ǣ˹һϰ˹ȫˣѧ򵥵˵
ɼҰǴѧԱȡԭʼݲɼҰԼͶ
󣬸޸ʱʹ۸ݣķݵ飬Щ
ݻӰĵҪ۵㡣˰·62ɼҰһӢ
һڹͶҰҪݵʱѡܶͬжΪ
еϧͲֵҲٶ󲻽⡣ɼҰԼʾȫΪĳλѧ
ĿҲý屨ΪɼҰǡΪҵձѧ˻
رоԱֻڽֹǰύġݡÿš2006923
գ

ɼҰǹ֪ķѧңʦNicholas CozzarelliԺʿ
ǰȥԭPNASࣩ16صձһDNA
ȡùԻͳɾͣͻףT4 DNARNAøĿ
оµDNAۺøķֵȵȡȻ˲ˡĴ󣬵Կѧ
оĹӦʷᡣձԴµĴԭɼҰڱ˶Ա
¶Ĳִ̹ȻϣѧҲѸٽɼҰڸְЩֵй
ѧѧѧϰйԺʿѧɼҰȥ
֤Ҳȷ䣬ҲɼҰأȴʼմȥ
ֵǷʡ

ձѧѧرı¼СһЩҪ
ķΪɼҰʵҵ¼йأȣɼҰ
ʵȫϵ¶Ըʵĵ׫д޸ģ
˶ݵıȫ֪ɼҰоƻֲɶϸСֽɲͬ
ѧԱֱоֻɼҰһܹоȫֻȫò
ڶɼҰӶйʵϸ֤ΪʾһԺ
ݡʵϸڣֻעĵҪۡ⣬滹Դ
Ĵ󻷾˷ΪձоĹ췢չ˶о


йɼҰʵҵҲ٣ֻǳ̶ͬĵ׫
дͷɵʦɸѧ빤ԱԳе˵൱ձ
󡣵ʦĿиСݷֱɲͬѧ빤Աе
˾ռߡΪ˱صɼҰĸޣйʦобҪ
һձѧѧرı档

ѧ鱨(Ӣİ)
http://www.fbs.osaka-u.ac.jp/FinalReport20060921.pdf

ձѧѧ鱨棨ձ棩
http://wwwsoc.nii.ac.jp/mbsj/admins/ethics_and_edu/doc/WG_rep_and_iken
sho.pdf

ձѧѧ鱨棨Ӣİ⣩
http://www3.interscience.wiley.com/journal/122522967/abstract

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ѧڵĹ

ߣһλںı



ã
˵ѧеĹ£Ѻָ

ѧѧԺ7µ׵ƸԺ£һֱˮƽ
Ȼ˿ҲһЩѧԺԺͽٵӣҲûп
ѽ

Ȼ˵ˣ

ѧѧԺһڣϿe.tju.edu..cnϵְ
󿴵ֻ2˾ǲ˺صľֶΣ

7·ѧУ쵼ͽյʼָһѧ٣
£

ã

żȻĸУְĹʾϣּѧԺṩ
ѧϢʵ˶ʿо벩ʿоǣְṩ
ӦʵȻ෴

          һʵУ

ţʼˣһ˵ʼָٸʤһ

ã

żȻĸУְĹʾϣּѧԺṩĳ
ϢʵѧļָӦ5ڳҳ1꣬
A

ʾ

Ϊ˳ΪAϢ˼ӹ죡

1

200109-200210׵ŵĻоԺѧ뼼ITC-irstʿ

Ѿ6ϡ

2 200808-200812Gironaѧֹͬе
-оĿ

3 200810-200905ѧ߼ѧ

23 еʱص

Ŵη֪ĸУϵġǷŴ٣

ûкʵѡΪ˴

       һʵУ

ˣԭģ

쵼һѽ

ֲԺĳϮĲ֮أ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ҽԺƽڴ̱˳ԾһͶ

ߣС

ʦ

ãСĳ˿лΪѧĲиŬ

СѪȽϸȤ־ΪһλѪҽʦǰС
ĳѪվһϢҹרԤԱȼоȡ
չϢΪһ߷ಡѧ־ϵ¡
Сְݶڵĸ˽ܣԼ˵ڽڷ20ƪӢ
£в־СΪϲǳڣԺ
оڡǣû죬СȻƪͬ£
ҵһ߱ΪڣҲҵСױſ¡

ʦӢĺһ㲻һͶС޷Ӣȫģ
ժҪϿ90%ͬƪһͶˡ֪2ڵ20ƪ
ӢЩʲôݣһЩźɣ

ҹרԤԱȼоȡ½չ

ĿǰҽƴѧڶҽԺಡѧоƽ
ѧŶ޲ԤԱȼоȡ½չϤ
һɹѾõȨý塶ಡѧ־ϿɣΪҹ
оһµ̱

1: Am J Cardiol. 2009 Feb 15;103(4):512-4. Epub 2008 Dec 25. Links
Role of probucol in preventing contrast-induced acute kidney 
injury after coronary interventional procedure.
Li G, Yin L, Liu
T, Zheng X, Xu G, Xu Y, Yuan R, Che J, Liu H, Zhou L, Chen X, He M, 
Li Y, Wu L, Liu E.
Department of
Cardiology, Tianjin Institute of Cardiology, Second Hospital of 
Tianjin Medical University, People's Republic of China.
Enhanced
production and reduced removal of oxygen free radicals may play an 
important role in the pathogenesis of the contrast-induced acute 
kidney injury (CIAKI). Probucol, a lipid-lowering drug with potent 
antioxidant properties, has been widely used clinically for the 
prevention of the progression of atherosclerosis. We performed a 
prospective, randomized controlled trial to investigate the role of 
probucol in the prevention of CIAKI in patients undergoing planned 
coronary angiography (CAG) or intervention. The 205 patients who 
underwent planned CAG or intervention were randomly assigned to either 
the probucol group (n = 102; 500 mg orally twice daily) or the control 
group (n = 103). Renal function was assessed at the time of hospital 
admission and on days 1, 2, and 3 after the procedure. CIAKI occurred 
in 23 (11.22%) of the 205 patients. The incidence of CIAKI in the 
probucol group was slightly lower compared with the control group 
(7.84% vs 14.56%) but without significant difference (p = 0.13). The 
postprocedure mean peak of serum creatinine (1.15 +/- 0.49 vs 1.33 +/- 
0.78 mg/dl, p = 0.04) and the postprocedure increasing Scr from 
baseline (0.15 +/- 0.22 vs 0.25 +/- 0.21 mg/dl, p = 0.001) in the 
probucol group were significantly lower than those in the control group. 
In conclusion, prophylactic treatment with probucol during the 
periprocedural stage in patients undergoing coronary angiography or 
intervention has a preventive role against CIAKI.
PMID: 19195512
[PubMed - indexed for MEDLINE]
?
2лѪܲ־2009?37(5)
 ƽ ͮ ÷  ÷ ֣  
޲ԤԱȼ𺦵ٴо  
Ŀ Աȼյļ(contrast induced
acute kidney injury,CIAKI)ҽԴԼ˥ߵҪԭ֮һ,
ǰհԡٴ,ּ̽Χʹ޲ܷ񽵵͹״
ϼļ.ɸѡ200711120084
31ҽƴѧڶҽԺȶĽʹԺ,й״Ӱ
()״Ļ205.޲(102)
(103).޲黼ǰ3d޲500 mg,2/d.
ʹõͶԱȼ-⺣.ȫˮ12 h(1 ml
kg-1h-1).Ժʱ3 d.72 hѪ弡(Scr)ϻ
ֵ25%44.2 ol/L(0.5 mg/a)ΪCIAKI. 黼ߴ󲿷ָֻ
ͳѧ.CIAKIΪ11.22%.ػعʾ,Scr
132.6 mol/L(OR=21.11,95%CI 1.9556.06,P0.001)(Ccr)
60 ml/min(OR=4.19,95%CI 1.949.05,P0.001)Ĺܣ
(NYHA)(OR=6.23,95%CI 2.7314.21,P0.001)(OR=2.049,95%GI 1.19
5.25,P0.001)70(OR=3.52,95%CI 1.667.43,P0.001)״
ӰʾĹ״ƻ(OR=4.29,95%CI 1.999.24,P0.001)
CIAKI.޲CIAKIʽ϶½(7.84%14.56%),
ͳѧ.޲,Scrֵ[(101.6242.98)mol/L
(117.6768.77)mol /L,P=0.047]ScrĲֵ(Scr)[(13.49
19.61)mol/L(22.5018.31)mol /L,P=0.001]Խ.۶Բȶ
Ľʹܹ״Ӱ()״ƵĻΧԤʹ
޲б,𺦵.

 
(300211,ҽƴѧڶҽԺ) ƽ
(300211,ҽƴѧڶҽԺ) ͮ
(300211,ҽƴѧڶҽԺ) ÷
(300211,ҽƴѧڶҽԺ) 
(300211,ҽƴѧڶҽԺ) ÷
(300211,ҽƴѧڶҽԺ) ֣
(300211,ҽƴѧڶҽԺ) 
(300211,ҽƴѧڶҽԺ) 
(300211,ҽƴѧڶҽԺ)

3 ֲѪҺ־?2009?7(1)
ƽ , ,ͮ ,֣ , , ,Ԭ ,
޲ԤԱȼ𺦵ٴо 

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

Ϻѧ÷սԾ֤֮

ߣ

ʿʦ÷Ůʿġġ תծȯ_붨ʵ֤
1 pdfͳ20093£282ڣP331340
³ơ÷ġעΪ1ҳ룩֮

롶÷ġͬйسɹֳڡ÷ġ֮
ǰ

 2йй˾תծȯʵ˼Ӧչй
ģ20031031ַ
http://www.studa.net/2003/10-31/20031031172744.html    ַ
http://www.sinology.cn/Article/2004/Article_1477.html2004-9-6
¹ѧ >> ϰѧ >> ¹ѧ >> о >> ѡ 

http://www.cf001.com/licai/rongzi/rongziyanjiu/2004/10-29/15491536.sht
ml2004-10-29йͶʣо 
1÷ġ331ҳ1Ρ2Σո2һ23й
ֶ֣ιңȫճԼ420ַ
2÷ġ332ҳ1Σո2һ4й֣ȫ
Լ90ַ

 3ڿתծȯģ͵о֣Сӭ½ͣԤ
⡷19993ڣP4043

1÷ġ332ҳ1µ2Σո341ҳ4µ
2й֣ȫճԼ98ַ

 4΢۽ѧѧ (,廪ѧ磬
2003-11-111¡ƫ΢ֵַ̺P532-553,549ҳ
11.3.1 µ1й΢ֱʾ)

1÷ġ333ҳ1.3µ3𣬣715й΢ֱʾ
й֣ո4,΢۽ѧѧ 廪ѧ
磬2003-11-111¡ƫ΢ֵַ̺549ҳ⡰11.3.1 
µ111521157йй΢ֱʾ֡Լ300


 5Ծһɢµ޽ṹģ͡лࡢΰ
üо200111ڣP3840
1÷ġ340ҳ⣨2һΣո538ҳ1й
֣ȫճԼ155ַ

÷Ůʿġġ˳ɹעֲţΪ
Уʹ֮ΪԼġʵʲ֣ѹɳϮΪ
ģ÷Ůʿ20093·ġġȻ
ݳϮ1063ַؾ֤£

20093£282
ոڣ2008219
յ޸ĸڣ2008818

תծȯ붨ʵ֤
÷ա
ϺѧʹѧԺ, Ϻ200444

÷1
0 
ͨծȯ,ת˾ծȯһָСתĹ˾ծ
ȯġתһָȵԼ, ծȯ߿ڽĳ
涨ڰԼתΪ˾ͨƱծȯ, ʵʾȨ
(Options)һֱʽ, ƱϹȨ֤MsrrsntsΪƣ
԰ѿתծȯծȯ롰ϹȨ֤໥ںϵһִ͹
ծȯHybrid Bonds
ġת Ȩ, ʹÿת˾ծȯԼծȯ
ƱȨĲ, Ϊ˾ծȯһ, תծͬȷ
޺ʣ, ͨ˵ĳɹת, תծֿԹƱʽ, 
ծȯͨתծȨ˱Ϊ˹˾ɶһ, Ҫתծ
͵֮ϡȻ, ûйȨתΪ, Ͷǲܽ
ģ, תծȨ, ͶӵǷծȯתɹƱѡȨ
÷ġ331ҳ1Ρ2Σո2һ23й֣
ֶιңȫճԼ420ַ
ղ1
ͨծȯȣת˾ծȯһָСתĹ˾ծ
ȯġתһָȵԼծȯ߿ڽĳ
涨ڰԼתΪ˾ͨƱծȯʵʾȨ
OptionsһֱʽƱϹȨ֤WarrantsΪơ
ǿ԰ѿתծȯծȯ롰ϹȨ֤໥ںϵһִͽڹ
 ծȯHybrid Bonds
ġתȨԣʹÿת˾ծȯԼծȯ
ƱȨĲȣΪ˾ծȯһ֣תծͬȷ
޺ʣΣͨ˵ĳɹתתծֿԹƱʽڣ
ծȯͨתծȨ˱Ϊ˹˾ɶһԣҪתծ
͵֮ϡȻûйȨתΪͶǲܽ
ģתծȨʣͶӵǷծȯתɹƱѡȨ
2һ23й֣

÷2
ֶĵ, ͹ʹת˾ծȯ˳ʺͱյ˫
ع, , 뵥ĳʹ߻չ, ǶԷ, ǶͶ
߶, תծȯ÷ġ332ҳ1Σո
2һ4й֣ȫճԼ90ַ
ղ2
ֶĵӣ͹ʹת˾ծȯ˳ʺͱյ˫
عܣˣ뵥ĳʹ߻չȣǶԷˣǶͶ
߶ԣתծȯ2һ4й֣

÷3
¼裺1֤ȯгһԵЧг2Ͷ
һԵ, е֤ȯʾΪ޷ʣ3޽
׷û˰գ4ʱ԰޷ʴʽ𡣣÷ġ
332ҳ1µ2Σո341ҳ4µ2й֣ȫ
Լ98ַ
ղ3
¼: (1) ֤ȯгһԵЧг; (2) Ͷ߶
һԵ, е֤ȯʾΪ޷; (3) ޽׷
û˰; (4) ʱ԰޷ʴʽ𡣣341ҳ
4µ2й֣

÷4
޲ַҪ˼úĳϵ̩ռչ, 溯
õƫ΢֪ƫ΢ֵĶΪ[2]. ÷ġ333ҳ
1.3µ3𣬣715й΢ֱʾй֣ո4,
΢۽ѧѧ 廪ѧ磬2003-11-111¡ƫ΢
ֵ̺549ҳ⡰11.3.1 µ11152
1157йй΢ֱʾ֡Լ300ַ
ղ4
޲ַҪ˼úĳϵ̩ռչ
õƫ΢֪֡ƫ΢־ͶΪ.μ4,
΢۽ѧѧ 廪ѧ磬2003-11-111¡ƫ΢
ֵ̺549ҳ⡰11.3.1 µ11152
1157йй΢ֱʾ֣

÷5
2Դ̹㷺ӦڽڲƷĶк, ǹɼۡʡ
ʵĶ̴̬󶼼ѭɢ, Ҳ˵Щı仯
, Ծ,ĳЩͻ¼, ޽Σ
ı֤ȯгϵͳյ, ᵼ¹ɼۺʵľұ仯, Ծ,
, ϵԾһɢܸ̽õؽı仯̡÷
ġ340ҳ⣨2һΣո538ҳ1й֣ȫճ
Լ155ַ
ղ5
Դ̹㷺ӦڽڲƷĶк, ǹɼۡʡʵ
̴̬󶼼ѭɢ̣diffusion process , Ҳ˵Щ
ı仯ܼ, Ծ(jump)(discontinuous)
ʵĳЩ, ͻ¼޽Σı޴
Ӱ, Ӷ¹ɼۡʺʵı仯Ծ, , ϵԾһ
ɢܸ̽õؽı仯̡538ҳ1й֣

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ɳ滮Ҵɳˮҥ

ߣˮ

ɳҹҪɲ֣ຣءĴʡ
ȫԼ35005100ףԼ50ƽ
Դḻӵˮܡɭ֡εڶصԴȻ
⣬ͨ㣬Ŀǰᾭ÷չͺԴ
ó̶ȲߡŹ󿪷սԵʵʩԴҪתΪ
ƣɳ򽫳Ϊҹ߿Ǳ֮һ

ȻڽɳεһЩվǷȱ֮ͣ
Ϲһɳˮ翪硣һЩαרҹѹһЩ
ҶԺˮʹʲ˳40%Ľ飬ˮˮνߡ
ҹĽɳˮ滮һʵʩˮˮﵽ83%س
ʾߡ˵ҹɳĹеҵӦ
ٻɳΪҪˮµĳۺϹ滮̨֮ǰ
췹

֪һɺϣйزŹҪʵ¶Щɳ
ˮ翪ҥԡ200981314գˮڱٿɳۺ
滮רᡣҪ֪ɳ滮ǼµĳۺϹ滮һ
ɲ֡μĸרΪ滮ƵλعĻϣ
տѧչ۵Ҫ˴Ŀ顢֤͹滮ƹעع
νЭ滮ָ˼ȷݽȫ棬岼ֺ
У滮޸ƺ󣬾챨Ժ

黹ǿɳˮԴڳͱռҪλ
Ҫ¼档

һǽɳˮԴḻ֧ˮԴ̲Ϊ1.21ǧߣ
ռˮԴ̲42.25%üɿΪ1.19ǧߣ
5927ǧʱռ49.9%ҹҪˮأʵʩ
綫սԵҪԴ㡣

ǽɳˮ߼еˮ̵ˮԴءˮ߹̶
ٽ󿪷սԵʵʩ̬뻷ٽСЭ
չлԶӰ졣иԭʡˮԴȱ
Լ˵ؾᷢչýˮۺͳõˮԴĻ
ϣӽɳˮõȱˮ⣬Դٽؾɳչ
شá

ǽɳݼ÷ݵɷֵεʹ
Ӷεķ񡣽ɳѴںˮռ˲ϳˮ֮һ
ҲǴˮҪԴ֮һϿˮŦܿõ£ɳ
ݼϿˮãһ߳εķ׼ٷ
á

ǽɳˮԴÿЧٽЭչھᷢչ
ͺˮʩΪϡȺӹˮԴìͻ
ҪڼǿˮĻϣˮԴ˽ҪṢ́̇
ˮũˮũҵȵˮ󣬴ٽ򾭼ֺֿ췢չ

ǽɳˮԴˮֶάҪǿɳˮ
Դˮʧۺǳ뱣Ҫɲ֣Դٽ
ϵ򾭼ɳչԶս塣

Ҫ˵ǣڽҹˮ滮ŶԽɳĽһ
̽оµۺϹ滮еĹڽɳˮĿɿûм٣
ӡµۺϹ滮ҹɳˮ7Ͽ֮
󷢵󳬹ҹĿǰѿȫˮ硣Լ൱ÿΪҹṩ3
ڶԭúԴˣǰһЩ˻ʿɢģ˾Ҫ
ƴҪ¹滮̨֮ǰɳҥԣɽơ

һ޴ϲѶÿһй޲裬ֳƿ졣Ԥ
ԣڵǰҹ̼ŵѹǿ£ڲϢĽɳ
ǵԴǵĽлʵֿɳչϣ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ѧѧԺĹͣʮģڵ͸ԵϢ

ߣ

ѾôойصļˣѧԺҳϵ
Ϣ̲סһѡ

http://www.coe.pku.edu.cn/subpage.asp?id=1449

ѧԺԹ򼰵Ϣ 

--------------------------------------------------

ʱ:2009-3-18 14:19:26:2137 

ѧԺж˶ʿôôѧԺĿ
200/꣡Ҫ󱨿ѧԺϵܷ300ϣӢξ
50֣רҵβ90֡δμӱרҵԵĿ
ѧԺĿ3191600ǰ˲͵ѧѧԺѧ¥311
ⱱ50ף˾ṹҪ󡭡Ŀ⡭Ŀ
롭μӱרҵδͨҲԵȻˣΪλ
ǰǿδμӱרҵԡ¡

2009깤ѧԺ˶ʿоԹԣ


http://www.coe.pku.edu.cn/subpage.asp?id=365

μӹѧԺԵıԿĿص 

---------------------------------------------------

ʱ:2006-9-23 7:25:59:1198 

빤ѧԺѵݽϵѧûнӵѧԺĵ绰֪ͨ"
μӸʸ",9268:30ѧ¥μӱ.˭ܿ仰
ӱҲͰˣһ֣ʵ֪ơ ɸԼ
ѧרҵѡһ⡣

ԣ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ҵĺС񫡱

ߣ÷

ĥŰﺢڽѧǰļһݹͬ
Һ͹ڵһϵܲȥ򹤡㺢Ӷٵԣ
֪ѵĹ˾ϷĿӲ޵̹ף
Counter StrikeˮƽԽҶӣðһ

ҵĺӰϷСѧʱҲԼӸ
ʲôģа취򿪣ôģ˵࿪εԻ
ͽȥˣ֪ǲġѧԺѧУϷ
԰ǮʡϷҲûа취ʱѧϰɼڰϴ
£Ҳͦżѧϰ϶ûзֻϣͨ
μӿתİá֪ҶϷ̬ȣȻڼ
ÿһԻ࣬û,ԴӲ̸Ϸ¡
òôˣҲûúʲôԭֻˣ
ˡ

˿8ºţȻôļҳΪơ񫡱
ѷ£ڹֲѹһ᲻
29%һأ

Ұ˿ıʱôôãô˵ģ

˵ǲǵüǰȥһϷʱ϶
ҿҵˮƽCounter Strikeÿӵе˵ͷ
ʱ30ӵȥֻУҲһǴҪ֪Լ
ɵ棬ҾͻؼҲ˼ſͷҲʼһЩԣ
ЩserviceľͿʼҵIPˡҲҪһ
Ҿͻһط棬ҲˡҿʼϲһЩ
飬۰˹Ļ飬˭дʱʷģе㲻
Լ䣩Щƽ̸ĶҺе
ҲԼϷ̫ʵ˷ʱˡҲμһ
Ϸteamȥ׬Ǯ֪㲻֧ңϷʱģ
˵ļɲȫ˷ѣҲûʲô˼׷µ棬Ͳˡ
ֻæѹʱɷɷ˵磬ˬһ¼ѹˡ
ôæʱҾȥѴˡ

Ļ൱⣬ۺʱʷ񫰡ϲ
֪ȥӪҴδϷİ
ʲôϵҲ̫֣һˣһǺӣ᲻񫣨
һ񫣩ž˵ģ״̬йء
ҳͺӹͨȽϺãϰӱȽаȫУѧУҲ죬
ӦöԺӡ񫡱аġ뼸ǰڼѧУʱ
ȷʵн϶ĸƣʱҲһЩθУе
¾ͿǼҲиʦѧҵͰ
ҲнҲһ㣬ƢһЩЩŶǺõذɡ
ǸܺõĺӣһҲˡ

ͬǸȥġꡱСŵȥάٿ˹ڵ
˵
羷ƷֳƵƷǾɵԲķʽշϣƾ
񼲻ķʽ˾֢˫м;֢
Ʒ䵱ҩƷЧʱԴ1930ִ
ͼɳڼʹ£൱ȫΪо񲡻ĻиŮ֮
ȫƷ(Ϊҩ̥ܶ˺ͻ̥Ʒֻ
ԲԽϰȫ)ûг鴤ɵĹۻݶ
ѵĲ֢ҽʦͻΪǹܵ˺
ĿǰĵƷͼɳڣ˲ƹ̲оʹ
ͲʡԵأδͼɳڣΪֱӵƣڴ󲿷ݹұ
ΪǷǷģδԱԸľ񲡻

СŵȻǱһ˿־ֶõģ϶û
ͼɳڡ

ҳǣھǵĺȥħѵӪǰǵĽͰ
ȫɣ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ָ䷽⡱ º

20090819ÿվ

ÿ  Ա

ºǱָƭ֣񲿵ֱա2007
8£¼ֱԼϺ̸Ϸͥԭºʵ
걨׼䷽Ҫԭϲ˴ԭͬ

ɡɣ족תΪ֮꣬ı򷴸ʱһȱܹע
ıʳƷº粨

86գġְҵˡһֽ״ºᾭ̱԰
ѩóģ¼԰ѩϷͥ԰ѩ¼ġ¡
ƺὺҺС˲߰ɷ֣䷽ͬգзɽ
Ժʽºᱱһտͥ

죬԰ѩԱʾ漰ҵܡͽҳɷⲻ


ͼ˲߰

ҵƭ֡ɷ١ӵСй̱ꡱ
¡ƺὺһĲƷ˵Ʒ
ʼעҰ

5£¡ƺὺͽġ
ԤҽѧоԺ⣬òƷ˲߰Чɷ֡δ
ϣʾºƷʵ䷽걨׼䷽
ҪԭϲѾãҲ˳ƺὺҺо 
áЧԭ򡣡˵ԣʱ˲Σû
Ӧ𣿵ᲢӪʣԶ˻кϣͨϣ
ܵõȷ˵

ǰйز֤֪¼걨׼
ºὺңҪԭΪ̶СͺڶͨøⷽʽƳɵ
Ʒвܲ˲γɷ֡죬Ԯҽѧ̿ƣֻͨ
ʲܺ˲߰ɷ֡

ʵºɷϣǵһԭ档20078£
¼Źɷ޹˾ͱľ̡ϺƼ޹˾Ϸͥ
״¼ºƷʵ䷽걨׼䷽Ҫ
ԭϲΥˡʳƷ취ʳƷйع涨
˾ʧ

죬ϺƼ޹˾Ĵʦɽʦʦ
θߡÿվšߣоΪ֮ǰ漰
˻ϣĿǰѽܷԺöֹҪ֮ǰо֮
С

ߣ԰ѩԱ֣˵ߣѾ֪ˣ
˾زϡǸС飬˽´Ϳˡ
һԳսӪʾ˲߰˲£û
Ҳܲ˲߰ŷ˵ס

ѯĿǰºԭϳɷ֣ո˳ƣҵܣ
˵

º

ºѾãºᲢδͣ

¼վܳƣºԵߵڣ߹ܣ
ƣ͡˥ϵáվû˵ҪɷǷڡ˲
߰

2007꣬ڷֲַ߶գϺƼ
޹˾ھ3ֹͣºᡣù˾ܲᲩýʾ
200711£ʳƷҩƷලֽౣʳƷĲȺɡʹ
综ߡΪʹ综ߡѪߡ쳣ߡҪѻñ
ʳƷ׼֤ҲȺΪʹ综ߡĺౣʳƷ2008111
ĲƷǩ˵бĹ

գ߿߹ºὺװϣעȺ
Ϊʹ综ߡδġ

ߡÿվšߣǰºܵɣ
ƷԭҲйزŴġٶʿӳƣ
ҹܾ֡ͨºᡱ⡣
öŵߵѧҲϵŵ߷
塣2006꣬ºᡱ걨ϴزʵͨýвʵ
⣬񲿽ֱӪ֤

Ըɣ죬԰ѩӪȻ˵ºƷû
⣬Ҫôܳʮꣿ

йֹ̾ʾ԰ѩóΪҵ20067
ڱзɽһԪעӪΧΪ۱ʳƷ¼
վʾΪ䱱ۻ

ͬʱҩ־ٱ

ǻ׼ȷϢ¼Ը˲Ʒ䷽죬
ߡÿվšߡ

ºƷɷֵ⣬ڵõר۵ͬʱͨ
¼ŵڲ֪¼֪ԭ걨ĲƷ䷽Ч
ԣԸãΪгݶҪӻ߷õʱ䣬
ȷʵ԰ѲƷ䷽Ϊ ˲ξҶ߰ۡҶͪάCάE
5-ᡱֶøõĺ5-档

ݴΪ¼ԸעƷ䷽ûκμ
Ʒϱ彡밲ȫҪǰͣ£Ȼг۸ֲƷ
թߣΥˡȨ汣Ʒ͡ʳƷ
취ʳƷع涨۲ϱȫı
Ʒթߣֺ߶Ʒ֪ȨӦ涨⳥
ߵļۿصĹһӦ

ϵͬʱѽ¼Źɷ޹˾ֵһϵ
ʳƷҩƷල־ٱѱ

շ壬¼δԴӦ

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

ֵ廪԰ռ



ŸеظеԵġһЩƨߵĽӲҪǼ!
ǧˣį֮С

ʮ

ҹһҹ磬ȻûͣƸ͡

ƽǸõطΨÿ괺Ĵʵᡣ
ûʲô¡ģЩ쵰ڣ֪Լй
쿼㿼ҿʲô?



FaustSummary
۶õ飬even Fausteven Faust
ֻҪαҸоᣬΪʲô?Ҳˡ
翴Ůȥ۴룬ֻȥȡ
Ϊ˵ʵڴòá



춼ԤPhilologyġҽʲô?test
reading reportеܲˡ



糿Philologyá
FaustSummaryҲġ
⼸һΪ̫࣬ʵڻΪԼ̫Hlderlinʫ
һֱûʹѹΪʲôԼܶԼ?˻Ĳ˳
ͷԼԸ(д£Ҳ)




ַë۶飬ȴȥԭԼףΪ
־ûйѹԴˡҿһܰëĵ?ϵۡ
ؿ˵HlderlinҲ𾢣ֵȥ

ʮ

ʼģǡۡ޿ɡۡ
һϣһ롣 ˵ҵҪʮҳ
˵ʵд˶ʮҳֲܲΪѣֻӲͷƤˡ

ʮ

쿪ʼҵģ۵ݲᣬᡣ

ʮ

쳭һҵģʹ

ʮ

ڳˡգ߳˳ǱҵġȻ֮
ҵȴıҵˡ
ϷǱ̸Ǳʮ˳ɺˣǳfrank
⼸쾻æЩĹڴǰѸýĶ꣬л
ʼдԼд

(XYS20090819)

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)

һΪ˰޷˿վĹ˽˿վĶ̬ؿ
˿ʼбxys@yahoogroups.com

ʼбÿ췢һ˿վ¸µϣÿµ׷һÿ
Ŀ¼ʼбĶμ롰˿֮ѡ
ʼбxys_friends@yahoogroups.com

ù䶩ġù䣬ܿ޷յ
Ƽ䣺yahoo.com, hotmail.com, gmail.com

ġ˿ʼбĵ䷢һհż

xys-subscribe@yahoogroups.com 

塢ͣ˿ʼбͣ䷢һհż

xys-unsubscribe@yahoogroups.com 

Ͷxinyusi@yahoo.comôıļͶ塣

˿(www.xys.org)(xys3.dxiong.com)(www.xysforum.org)(xys2.dropin.org)
